The original article can be found online at https://doi.org/10.1186/s40545-021-00345-4.
Correction to: J Pharm Policy Pract (2021) 14:59 https://doi.org/10.1186/s40545-021-00345-4
Following the publication of the original article [Citation1], the authors notified us of a few mistakes:
In the Results section of the Abstract, “disease severity (β = − 0.143; SE = 0.043)” should actually read “cost burden for the government (β = − 0.140; SE = 0.050)”.
In the Results section of the body of the article, the phrase “Increasing survival after treatment was the most important attribute in the present study (36%), followed by promoting QoL (27%), alternative treatment” should read “Increasing survival after treatment was the most important attribute in the present study (34%), followed by promoting QoL (26.5%), alternative treatment”.
In the 7th paragraph of the Discussions section, the phrase “The last attribute for entering a drug into the list of subsidized drugs was disease severity” should read “The fifth important attribute for entering a drug into the list of subsidized drugs was disease severity.”.
In the 8th paragraph of the Discussions section, the phrase “The fifth important attribute for entering a drug into the list of subsidized drugs was the cost burden for the government.” should read “The last attribute for entering a drug into the list of subsidized drugs was the cost burden for the government.”.
In Table 4, the values for the relative importance (last column) are changed:
36 becomes 34.1
27 becomes 26.6
17.20 becomes 22.6
13.10 becomes 7.8
3.40 becomes 4.1
3.30 becomes 4.8
The original article has now been corrected.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Reference
- Delpasand M, Olyaaeemanesh A, Jaafaripooyan E Abdollahiasl A, Davari M, Karyani AK. Eliciting the public preferences for pharmaceutical subsidy in Iran: a discrete choice experiment study. J Pharm Policy Pract. 2021;14:59.https://doi.org/10.1186/s40545-021-00345-4.